(Q36839125)

16 August 2017

1 reference

title

The potential importance of swainsonine in therapy for cancers and immunology (English)

1 reference

16 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

16 November 2022

author name string

K. Olden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1754603

16 November 2022

P. Breton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1754603

16 November 2022

K. Grzegorzewski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1754603

16 November 2022

Y. Yasuda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1754603

16 November 2022

B. L. Gause

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1754603

16 November 2022

O. A. Oredipe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1754603

16 November 2022

S. A. Newton

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1754603

16 November 2022

S. L. White

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1754603

16 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1754603

16 November 2022

publication date

1 January 1991

1 reference

full work available at URL

16 August 2017

https://api.elsevier.com/content/article/PII:016372589190046O?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

https://api.elsevier.com/content/article/PII:016372589190046O?httpAccept=text/plain

16 November 2022

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Pharmacology & Therapeutics

16 November 2022

published in

1 reference

16 August 2017

50

1 reference

16 August 2017

3

1 reference

16 August 2017

285-290

1 reference

Swainsonine, an inhibitor of glycoprotein processing, enhances mitogen induced interleukin 2 production and receptor expression in human lymphocytes

16 August 2017

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Potentiation of human lymphokine-activated killer cell activity by swainsonine, an inhibitor of glycoprotein processing

16 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Swainsonine modulation of protein kinase C activity in murine peritoneal macrophages

16 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

The indolizidine alkaloids, slaframine and swainsonine: contaminants in animal forages

16 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models

16 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

A Spectroscopic Investigation of Swainsonine: An α-Mannosidase Inhibitor Isolated from Swainsona canescens

16 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Inhibition of human HT29 colon carcinoma growth in vitro and in vivo by swainsonine and human interferon-alpha 2

16 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Inhibition of lysosomal alpha-mannosidase by swainsonine, an indolizidine alkaloid isolated from Swainsona canescens

16 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains

16 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Swainsonine: an inhibitor of glycoprotein processing

16 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease

16 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

The Biology of Cancer Invasion and Metastasis

16 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Dose: a critical factor in cancer chemotherapy

16 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Induction of macrophage tumoricidal activity, major histocompatibility complex class II antigen (Iak) expression, and interleukin-1 production by swainsonine

16 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Role of natural killer cells in control of cancer metastasis.

16 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells

16 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity

16 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Studies of an immunomodulator, swainsonine. I. Enhancement of immune response by swainsonine in vitro

16 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer

16 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Asparagine-linked oligosaccharides and tumor metastasis

16 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells

16 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors

16 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells

16 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Studies of an immunomodulator, swainsonine. II. Effect of swainsonine on mouse immunodeficient system and experimental murine tumor

16 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Loco intoxication: indolizidine alkaloids of spotted locoweed (Astragalus lentiginosus).

16 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Swainsonine Inhibition of Spontaneous Metastasis

16 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Carbohydrate moieties of glycoproteins. A re-evaluation of their function

16 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Function of glycoprotein glycans

16 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Experimental approaches for the prevention of hematogenous metastasis

16 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice

16 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis

16 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Effects of altering surface glycoprotein composition on metastatic colonisation potential of murine mammary tumour cells

16 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

The Lipid Pathway of Protein Glycosylation and its Inhibitors: The Biological Significance of Protein-Bound Carbohydrates

16 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Inhibition of Glycosylation of Viral Glycoproteins

16 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice

16 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

16 November 2022

Metastatic Inefficiency

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Metastatic inefficiency in mice bearing B16 melanomas

16 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Stimulation of DNA synthesis in murine lymphocytes by the drug swainsonine: Immunomodulatory properties

16 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

Swainsonine stimulation of the proliferation and colony forming activity of murine bone marrow

16 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0163-7258(91)90046-O

16 November 2022

Identifiers

1 reference

16 August 2017

1 reference